Research and Markets: Pharmaceutical Pricing, Reimbursement, and Market Access in Argentina

<0> Research and Markets: Pharmaceutical Pricing, Reimbursement, and Market Access in Argentina </0>

<0> Research and MarketsLaura Wood, Senior ManagerU.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Sector: </0>

() has announced the addition of Decision Resources, Inc's new report "Pharmaceutical Pricing, Reimbursement, and Market Access in Argentina" to their offering.

Argentina, the fourth-largest pharmaceutical market in Latin America and one of the fastest-growing markets in the world, may appear very attractive to multinationals, but achieving success in this country is by no means easy for outsiders. Foreign companies need to understand the structure of the Argentine healthcare system, the limitations of intellectual property protection, pricing trends, and coverage policies for prescription drugs. In addition, multinationals must be prepared for a general legal and commercial environment that presents formidable challenges.

- Executive Summary

- Strategic Considerations

- Stakeholder Implications

- Introduction

- Socioeconomic and Demographic Background

- Organization and Funding of the Healthcare System

- Social Security (Obras Sociales)

- Private Sector

- Public Sector

- Pharmaceutical Regulation

- Intellectual Property Protection

- Pharmaceutical Market Trends

- Pharmaceutical Pricing

- Reimbursement

- Social Funds and Private Insurers

- Public Sector

- Outlook and Implications for the Pharmaceutical Industry

Tables

- 1 Population Projections for Argentina and Other Major Markets in Select Years, 2010-2030

- 2 Life Expectancy at Birth in Argentina and Other Major Markets, 1950-1955 and 2010-2030

- 3 Percentage of the Population Aged 65 or Older in Argentina and Other Major Markets in 1950 and Select Years, 2010-2030

- 4 Healthcare Spending as a Percentage of Gross Domestic Product in Argentina and Other Major Markets, 1995-2009

- 5 Total Healthcare Spending Per Capita in Argentina and Other Major Markets, 1995-2009 (US Dollars)

- 6 Common Chronic Disorders Eligible for 70% Reimbursement of Reference Prices

Figures

- 1 Growth Rates of Argentine Gross Domestic Product, 2001-2010

- 2 Sources of Health Insurance Coverage in Argentina, 2011

- 3 Argentine Pharmaceutical Market: Ex-Manufacturer Sales in Pesos and US Dollars, 1994-2009

For more information visit

Source: Decision Resources, Inc

Suggested Articles

The Pharma Lions shortlist for 2019 lives up to its name with just 31 entries making the cut. But it's still good news for the 12 drugmaker finalists.

Pharma companies filed suit Friday to block the new HHS rule that requires drugmakers to put list prices in TV ads.

Cannes Lions Health kicks off Monday, and attendees are looking for some breakouts—leading-edge tech, creativity and inspiration, for instance.